14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
IPAR vs EPC: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
IPAR Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 7–3 Matrix Metrics)
IPAR Overall Winner
6-Pillar Tally: IPAR 4 – 1 EPC (1 Tie)
Matrix Metrics: IPAR 7 – 3 EPC
As of Nov 16, 2026, Interparfums, Inc. (IPAR) is the stronger overall head-to-head candidate over Edgewell Personal Care Company (EPC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). IPAR carries a Unified Composite Score of 31.7/100 (SELL) at $133.94 (26.2x Forward P/E, 17.9% operating margin), whereas EPC carries 42.0/100 (HOLD) at $27.27 (13.8x Forward P/E, 7.9% operating margin).
Composite vs. Pillar Nuance: While EPC currently prints a higher short-term Unified Composite Score (42.0/100 HOLD vs. IPAR 31.7/100 SELL), IPAR captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (17.9% vs. 7.9% operating margin) and revenue trajectory (+0.0% vs. -9.9% YoY).
Technical & Structure Timing Caution: IPAR trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 68.9); meanwhile EPC is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IPAR vs EPC. Trailing 12-month operating profitability (IPAR 17.9% vs EPC 7.9%) and valuation multiples (IPAR 26.2x vs EPC 13.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Household & Personal Products value chain with $1.3B market capitalization and 7.9% operating margin.
OpEx & R&D Reinvestment35.5% of Rev ($709M)
90D Engineering Disclosures0 Published
Investor FAQ IPAR vs EPC Key Questions & Quantitative Answers
As of Nov 16, 2026, Interparfums, Inc. (IPAR) is the stronger overall head-to-head candidate over Edgewell Personal Care Company (EPC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). IPAR carries a Unified Composite Score of 31.7/100 (SELL) at $133.94 (26.2x Forward P/E, 17.9% operating margin), whereas EPC carries 42.0/100 (HOLD) at $27.27 (13.8x Forward P/E, 7.9% operating margin). Composite vs. Pillar Nuance: While EPC currently prints a higher short-term Unified Composite Score (42.0/100 HOLD vs. IPAR 31.7/100 SELL), IPAR captures the overall institutional head-to-head verdict (7–3 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (17.9% vs. 7.9% operating margin) and revenue trajectory (+0.0% vs. -9.9% YoY). Technical & Structure Timing Caution: IPAR trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 68.9); meanwhile EPC is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 44.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
IPAR leads the Growth & Scale pillar: IPAR posts +0.0% YoY revenue growth and +3.9% YoY earnings growth on $1.50B TTM revenue (59.8% gross margin, 17.9% operating margin), compared with EPC at -9.9% YoY revenue growth and -53.4% YoY earnings growth on $2.00B TTM revenue (43.4% gross margin, 7.9% operating margin). On trailing 12-month operating scale, IPAR generates $1.50B in USD-normalized revenue versus $2.00B for EPC. In operating R&D and SG&A reinvestment, IPAR deploys 41.9% of Rev ($629M) (0 90-day corporate R&D disclosures) versus 35.5% of Rev ($709M) (0 disclosures) for EPC.
EPC screens cheaper on headline valuation multiples. IPAR trades at 26.2x Forward P/E, 24.6x Trailing P/E, 3.20x PEG, and 2.8x EV/Revenue (19.5% EBITDA margin), whereas EPC trades at 13.8x Forward P/E, 14.5x Trailing P/E, 2.87x PEG, and 0.7x EV/Revenue (11.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IPAR (19.0% ROE) versus EPC (-0.1% ROE) capital efficiency.
In options market volatility and institutional positioning, IPAR carries 41.0% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 43% Vol realized risk). By comparison, EPC carries 40.9% implied volatility (5th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.34β · 52% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.